Skip to content

"Effectiveness of Ailurophobia treatment by virtual reality"

Effectiveness of Ailurophobia treatment by virtual reality compared to metacognition treatment

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230105057057N1
Enrollment
28
Registered
2023-03-04
Start date
2022-03-21
Completion date
Unknown
Last updated
2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ailurophobia. Specific (isolated) phobias

Interventions

Intervention 1: After the approval of the psychiatric specialist for the diagnosis of the patient, the patients are placed in 2 groups of 14 people between the ages of 18 and 45, male and female. Each

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Patients who have been confirmed according to the diagnostic interview based on the relevant symptom checklist in the fifth edition of the disorder diagnosis, diagnostic and statistical manual of specific phobias (fear of cats) Patients who meet the criteria of fear of cats for at least six months Patients who are in the age range of 18 to 45 Patients are satisfied with participating in this research

Exclusion criteria

Exclusion criteria: Patients who are absent for more than three sessions in treatment sessions Patients who are dependent on alcohol or drugs Patients who have other mental and physical problems at the same time Patients who are treated with other methods of drug therapy and psychotherapy during the trial period Patients who do not want to continue treatment for any reason

Design outcomes

Primary

MeasureTime frame
Ailurophobia. Timepoint: The beginning of the study, 1 month and 3 months after the start of the study. Method of measurement: "Kettle questionnaire", "construction of ailurophobia author".

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAlireza Ebrahimi

Mashhad University of Medical Sciences

arjmandim981@mums.ac.ir+98 51 3711 2701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 6, 2026